Accumulated studies have demonstrated that RosA possesses immunomodulatory effects for alleviating chronic or acute inflammation diseases (such as arthritis, colitis, asthma and lung injury) through acting on multiple molecular targets, including NF-kB, p-STAT3, and MAPKs [23]. Here, NFKB1 is linked to asthma.